News
Anne Wojcicki to buy back 23andMe and its data
Digest more
Testing firm 23andMe has been fined more than £2m for failing to protect the sensitive personal and genetic data of more than ...
Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a ...
Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results